Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-225467
Filing Date
2012-05-10
Accepted
2012-05-10 16:04:53
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d339357d10q.htm 10-Q 746137
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d339357dex311.htm EX-31.1 8731
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER d339357dex312.htm EX-31.2 8716
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d339357dex321.htm EX-32.1 3603
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER d339357dex322.htm EX-32.2 3620
  Complete submission text file 0001193125-12-225467.txt   2794931

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cemp-20120331.xml EX-101.INS 354475
7 XBRL TAXONOMY EXTENSION SCHEMA cemp-20120331.xsd EX-101.SCH 20352
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cemp-20120331_cal.xml EX-101.CAL 31160
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cemp-20120331_def.xml EX-101.DEF 74959
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemp-20120331_lab.xml EX-101.LAB 165501
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemp-20120331_pre.xml EX-101.PRE 120328
Mailing Address 6340 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149
Business Address 6340 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149 919-313-6617
CEMPRA, INC. (Filer) CIK: 0001461993 (see all company filings)

EIN.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35405 | Film No.: 12830244
SIC: 2834 Pharmaceutical Preparations